Disease immunotherapy is an approved and fundamentally significant methodology for rewarding patients with malignancy. Given the tremendous research and clinical examination endeavors devoted to progressing both endogenous and engineered immunotherapy draws near, there is a need to concentrate on pivotal inquiries and characterize barriers to the essential understanding and clinical advancement. Here, we characterize ten key difficulties confronting malignant growth immunotherapy, which extend from absence of trust in making an interpretation of pre-clinical discoveries to recognizing ideal blends of resistant based treatments for some random patient. Tending to these difficulties will require the joined endeavors of fundamental scientists and clinicians, and the centering of assets to quicken comprehension of the perplexing cooperation among malignant growth and the resistant framework and the advancement of improved treatment alternatives for patients with disease.
Research Article: Immunochemistry & Immunopathology
Research Article: Immunochemistry & Immunopathology
Research Article: Immunochemistry & Immunopathology
Research Article: Immunochemistry & Immunopathology
Research Article: Immunochemistry & Immunopathology
Research Article: Immunochemistry & Immunopathology
Review Article: Immunochemistry & Immunopathology
Review Article: Immunochemistry & Immunopathology
Review Article: Immunochemistry & Immunopathology
Review Article: Immunochemistry & Immunopathology
Keynote: Medical Microbiology & Diagnosis
Keynote: Medical Microbiology & Diagnosis
Posters & Accepted Abstracts: Medical Microbiology & Diagnosis
Posters & Accepted Abstracts: Medical Microbiology & Diagnosis
Posters & Accepted Abstracts: Medical Microbiology & Diagnosis
Posters & Accepted Abstracts: Medical Microbiology & Diagnosis
Posters & Accepted Abstracts: Medical Microbiology & Diagnosis
Posters & Accepted Abstracts: Medical Microbiology & Diagnosis
Scientific Tracks Abstracts: Journal of Antimicrobial Agents
Scientific Tracks Abstracts: Journal of Antimicrobial Agents
Immunochemistry & Immunopathology received 174 citations as per Google Scholar report